Researchers are identifying molecules that interact with neurolysin, a peptidase that helps protect the brain against stroke.
List view / Grid view
Scientists have revealed a way to use gene therapy to turn glial brain cells into neurons, restoring vision and potentially restoring motor function.
Inter-alpha inhibitor proteins (IAIP) demonstrated efficiency in reducing damage from an ischemic stroke, reveals pre-clinical study.
Researchers have shown that an mRNA delivery system can be used to produce the BDNF protein in rats to protect neurons from ischemia.
Researchers have shown that adding a polymer to glutamate-oxaloacetate transaminase means the molecule can treat stroke for up to six days in rats.
The novel nanoparticle delivered Mp6 peptide was able to inhibit thrombosis and reduce inflammation without increasing the risk of bleeding in mice after heart attacks.
Administering a novel complement protein blocker (B4Crry) alongside reperfusion therapy improved cognitive and motor recovery in a model of ischemic stroke.
Research has found that after stroke in mice, B cells migrate to far regions of the brain that control motor functions, indicating their role in recovery.
Scientists conducted a pre-clinical trial in mice and showed that activating the retinoid X receptor (RXR) enhances the activity of phagocytic immune cells and aids recovery from stroke.
A novel hybrid approach has revealed a 3D structure of a protein fragment that could serve as a drug target in treating stroke patients...
A new study shows e-ASPECTS correlates with and is a predictor of outcome after mechanical thrombectomy. With mechanical thrombectomy gaining ground as a possible treatment for patients suffering from acute ischemic stroke, it is even more important to select those patients who can derive the most benefit.
The use of benzodiazepines and benzodiazepine-like drugs was associated with a 20% increased risk of stroke among persons with Alzheimer’s disease, shows a recent study from the University of Eastern Finland.